Ketorolac trometham
Ended Awarded
- Contract number
- SPE2DP25F8878
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,042
Award facts
- Contract value 100% obligated
- $1,041.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,041.60 to DMS Pharmaceutical Group Inc. for the supply of Ketorolac Tromethamine, a nonsteroidal anti-inflammatory medication commonly used for pain management in military healthcare settings. This firm fixed-price delivery order, issued on June 27, 2025, with an ultimate completion date of July 7, 2025, represents a discrete purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, maintaining a comprehensive portfolio of branded and generic prescription drugs, over-the-counter medications, and specialty pharmaceuticals for military health facilities. The company holds a significant single-award IDC valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for pharmaceutical items supporting medical supply needs across Department of Defense healthcare sites worldwide. This delivery order for Ketorolac Tromethamine exemplifies the routine pharmaceutical replenishment orders issued under this larger contract vehicle to maintain adequate medication supplies for military medical operations.
Quick answers
Who was awarded contract SPE2DP25F8878?
SPE2DP25F8878 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 27, 2025.
How much is contract SPE2DP25F8878 worth?
The government has obligated $1,042 on SPE2DP25F8878.
Is contract SPE2DP25F8878 an order under another contract?
Yes. SPE2DP25F8878 is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F8878 competed?
The extent of competition for SPE2DP25F8878 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award